Dr Reddy's Labs earmarks Rs 1,500 crore capex with focus on biosimilars, injectables Ruchika Sharma7 Nov 2022 2:30 PM ISTNew Delhi: Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities...
Dr Reddys Labs bags CDSCO panel conditional nod to manufacture, market Nimesulide Granules Dr. Nandita Mohan22 Oct 2022 1:18 PM IST Stressing that the drug product should only be made available with a prescription from a Registered Medical Practitioner, the Subject Expert...
Health Bulletin 21/October/2022 Dr. Nandita Mohan21 Oct 2022 5:43 PM ISTHere are the top health stories for the day:MBBS Admission: Bombay HC orders medical re-examination of student with locomotor disabilityWhile...
Dr Reddy's Labs, Cipla facilities join World Economic Forum Global Lighthouse Network Ruchika Sharma12 Oct 2022 12:08 PM ISTOn Cipla, the WEF said the company deployed digital, automation and analytics solutions to 22 Indian sites to preserve access to high-quality...
LIC increases its stake in Dr Reddy's Laboratories from 5.65 percent to 7.7 percent Ruchika Sharma4 Oct 2022 11:01 AM ISTLIC's holding in the company stands at 7.7 percent, it added.
Dr Reddy's Labs, IQVIA ink pact for CRM solution for India field force Ruchika Sharma29 Sept 2022 11:15 AM ISTOCE is IQVIA's CRM Application Suite that enables life sciences clients to digitally transform their sales and marketing operations.
Dr Reddy's Labs, DNDi ink pact to develop affordable drugs for neglected tropical diseases Ruchika Sharma1 Sept 2022 3:41 PM ISTNew Delhi: Dr. Reddy's Laboratories Ltd. and Aurigene Pharmaceutical Services Limited, a contract research, development, and manufacturing services...
Dr Reddy's Labs receives USFDA EIR for Srikakulam facility Ruchika Sharma26 Aug 2022 12:15 PM ISTNew Delhi: Drugmaker, Dr Reddy's Labs, has recently announced that the Company has received the Establishment Inspection Report (EIR) from the US...
Intercept Pharma resolves patent dispute with Dr Reddys Labs over generic Ocaliva Ruchika Sharma19 Aug 2022 3:03 PM ISTHyderabad: Intercept Pharmaceuticals Inc has said it entered into a settlement agreement with Dr Reddy's Laboratories resolving the previously...
Dr Reddy's Labs to acquire Slayback Pharma OTC ophthalmic product rights Ruchika Sharma30 July 2022 4:07 PM ISTSlayback Pharma is the first company to file an ANDA for the private label equivalent for Lumify with the USFDA under Paragraph IV certification.
Dr Reddys launches Bortezomib for Injection in US Rahul Verma29 July 2022 5:09 PM ISTDrugmaker, Dr Reddy's Laboratories Ltd., has announced the launch of Bortezomib for Injection 3.5 mg, the generic equivalent of Velcade (bortezomib)...
Dr Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in US Ruchika Sharma9 July 2022 2:55 PM ISTHyderabad: Drugmaker, Dr. Reddy's Laboratories Ltd., has announced the launch of the company's Fesoterodine Fumarate Extended-Release Tablets, a...
